The cellular microenvironment and cell adhesion: a role for O-glycosylation.
Glycosylation is one of the most abundant protein modifications in Nature, having roles in protein stability, secretion and function. Alterations in mucin-type O-glycosylation are responsible for a number of human diseases and developmental defects, as well as associated with certain types of cancer. However, the mechanistic role of this form of glycosylation in many of these instances is unclear. Here we describe how one glycosyltransferase responsible for initiating mucin-type O-glycosylation (PGANT3), specifically modulates integrin-mediated cell adhesion by influencing the secretion and localization of an integrin ligand. The integrin ligand Tiggrin, is normally O-glycosylated and localized to the basal matrix, where adhesion of two opposing cell layers takes place. In pgant3 mutants, Tiggrin is no longer O-glycosylated and fails to be properly secreted to the basal cell layer interface, resulting in disruption of proper cell adhesion. pgant3-mediated effects are dependent on the enzymatic activity of PGANT3 and cannot be rescued by another pgant family member, indicating a unique role for this glycosyltransferase. These results provide in vivo evidence for the role of O-glycosylation in the secretion of specific extracellular matrix proteins, which thereby influences the composition of the cellular 'microenvironment' and modulates cell adhesion events. The studies described in this review provide insight into the long-standing association between aberrant O-glycosylation and tumorigenesis, as changes in tumour environment and cell adhesion are hallmarks of cancer progression.
Developmental Glycobiology Unit, NIDCR, National Institutes of Health, Bethesda, MD 20892-4370, USA.
Liping
L
Zhang
Kelly G
KG
Ten Hagen
D000818:Animals; D002448:Cell Adhesion / Q000502:physiology*; D029721:Drosophila Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D004331:Drosophila melanogaster / Q000033:anatomy & histology / Q000502:physiology; D005109:Extracellular Matrix / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D006031:Glycosylation; D016695:Glycosyltransferases / Q000235:genetics / Q000378:metabolism; D006801:Humans; D016023:Integrins / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D017350:N-Acetylgalactosaminyltransferases / Q000235:genetics / Q000378:metabolism; D009369:Neoplasms / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D019076:Transgenes; D014921:Wings, Animal / Q000254:growth & development
D029721:Drosophila Proteins; D016326:Extracellular Matrix Proteins; D016023:Integrins; C089678:Tig protein, Drosophila; D016695:Glycosyltransferases; C550932:Pgant3 protein, Drosophila; D017350:N-Acetylgalactosaminyltransferases
Glycoconj J. 2009 Apr;26(3):325-34
18695988
J Cell Biol. 2007 Dec 31;179(7):1583-97
18166658
Nat Genet. 2004 Jun;36(6):579-81
15133511
Genetics. 1998 Oct;150(2):791-805
9755209
Nat Genet. 2004 Mar;36(3):283-7
14981521
Int J Cancer. 2006 Sep 15;119(6):1383-8
16596643
BMC Cancer. 2010 Apr 01;10:123
20356418
Development. 1994 Jul;120(7):1747-58
7924982
Curr Opin Cell Biol. 2003 Oct;15(5):607-13
14519396
J Biol Chem. 2010 Jun 18;285(25):19491-501
20371600
Development. 1998 May;125(9):1679-89
9521906
Glycobiology. 2003 Jan;13(1):1R-16R
12634319
Mol Cell Biol. 2007 Dec;27(24):8783-96
17923703
J Biol. 2003;2(4):27
14527345
J Biol Chem. 2002 Jun 21;277(25):22616-22
11925446
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12921-5
19617566
J Exp Med. 2007 Jun 11;204(6):1417-29
17517967
J Biol Chem. 2007 Jan 5;282(1):606-14
17098739
J Biol Chem. 1998 Jul 17;273(29):18235-41
9660786
Science. 2004 Feb 6;303(5659):832-5
14764878
Nature. 2005 Oct 27;437(7063):1252
16251947
Development. 1995 May;121(5):1311-20
7789263
Glycobiology. 2009 Feb;19(2):102-11
18824561
Clin Chem. 2006 Sep;52(9):1701-12
16873292
Dev Biol. 1993 May;157(1):49-59
8482419
J Biol Chem. 2008 Dec 5;283(49):34076-86
18835818